Zurich Cantonal Bank
HAE icon

Zurich Cantonal Bank’s Haemonetics HAE Stock Holding History

Zurich Cantonal Bank’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.38M Hold
18,339
– – ﹤0.01% 1349
2026
Q1 		$1.03M Buy
+18,339
New +$1.19M ﹤0.01% 1414
2025
Q4 		– Sell
-14,156
Closed -$951K – 2973
2025
Q3 		$690K Buy
14,156
+742
+6% +$45.9K ﹤0.01% 1531
2025
Q2 		$1M Buy
13,414
+18
+0.1% +$1.19K ﹤0.01% 1229
2025
Q1 		$851K Buy
13,396
+936
+8% +$63.7K ﹤0.01% 1260
2024
Q4 		$973K Buy
12,460
+1,202
+11% +$96.5K ﹤0.01% 1195
2024
Q3 		$905K Hold
11,258
– – ﹤0.01% 1178
2024
Q2 		$931K Buy
11,258
+3,274
+41% +$288K ﹤0.01% 1105
2024
Q1 		$681K Sell
7,984
-5,267
-40% -$413K ﹤0.01% 1281
2023
Q4 		$1.13M Sell
13,251
-195
-1% -$16.9K ﹤0.01% 1000
2023
Q3 		$1.2M Buy
13,446
+4,959
+58% +$443K 0.01% 883
2023
Q2 		$723K Buy
8,487
+465
+6% +$39.3K ﹤0.01% 1130
2023
Q1 		$664K Buy
8,022
+1,034
+15% +$83.7K ﹤0.01% 1132
2022
Q4 		$550K Buy
6,988
+485
+7% +$39K ﹤0.01% 1210
2022
Q3 		$481K Hold
6,503
– – ﹤0.01% 1220
2022
Q2 		$424K Sell
6,503
-548
-8% -$32.4K ﹤0.01% 1329
2022
Q1 		$446K Hold
7,051
– – ﹤0.01% 1398
2021
Q4 		$374K Buy
7,051
+1,945
+38% +$119K ﹤0.01% 1660
2021
Q3 		$360K Buy
5,106
+790
+18% +$49.9K ﹤0.01% 1510
2021
Q2 		$288K Sell
4,316
-605
-12% -$42.8K ﹤0.01% 1570
2021
Q1 		$546K Sell
4,921
-1,443
-23% -$179K ﹤0.01% 1169
2020
Q4 		$756K Buy
6,364
+721
+13% +$77.6K ﹤0.01% 1074
2020
Q3 		$492K Hold
5,643
– – ﹤0.01% 1103
2020
Q2 		$505K Buy
5,643
+1,495
+36% +$151K ﹤0.01% 1000
2020
Q1 		$413K Buy
4,148
+643
+18% +$69.7K ﹤0.01% 920
2019
Q4 		$403K Hold
3,505
– – ﹤0.01% 987
2019
Q3 		$442K Buy
3,505
+159
+5% +$20.2K ﹤0.01% 937
2019
Q2 		$403K Hold
3,346
– – ﹤0.01% 961
2019
Q1 		$293K Sell
3,346
-4,116
-55% -$374K ﹤0.01% 1025
2018
Q4 		$747K Hold
7,462
– – 0.01% 807
2018
Q3 		$855K Sell
7,462
-3,321
-31% -$344K 0.01% 820
2018
Q2 		$967K Sell
10,783
-1,349
-11% -$114K 0.01% 804
2018
Q1 		$888K Hold
12,132
– – 0.01% 801
2017
Q4 		$705K Buy
12,132
+3,483
+40% +$183K 0.01% 821
2017
Q3 		$388K Buy
8,649
+7,017
+430% +$292K ﹤0.01% 884
2017
Q2 		$64K Buy
1,632
+235
+17% +$9.65K ﹤0.01% 1613
2017
Q1 		$57K Hold
1,397
– – ﹤0.01% 1666
2016
Q4 		$56K Hold
1,397
– – ﹤0.01% 1642
2016
Q3 		$51K Buy
1,397
+223
+19% +$7.66K ﹤0.01% 1622
2016
Q2 		$34K Hold
1,174
– – ﹤0.01% 1721
2016
Q1 		$41K Hold
1,174
– – ﹤0.01% 1528
2015
Q4 		$38K Buy
1,174
+662
+129% +$21.5K ﹤0.01% 1589
2015
Q3 		$17K Buy
512
+250
+95% +$9.41K ﹤0.01% 1565
2015
Q2 		$11K Hold
262
– – ﹤0.01% 1321
2015
Q1 		$12K Buy
+262
New +$11K ﹤0.01% 1272
2014
Q2 		– Sell
-30,000
Closed -$978K – 1004
2014
Q1 		$978K Buy
+30,000
New +$1.15M 0.03% 536
2013
Q4 		– Sell
-210,360
Closed -$8.39M – 985
2013
Q3 		$8.39M Buy
210,360
+18,900
+10% +$793K 0.29% 75
2013
Q2 		$7.92M Buy
+191,460
New +$7.75M 0.28% 84

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Zurich Cantonal Bank's HAE Position: Q2 2026 in Review

Zurich Cantonal Bank held its Haemonetics (HAE) position steady in Q2 2026 at 18,339 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Zurich Cantonal Bank first reported a position in HAE in Q2 2013 and has held it in 48 quarters since. The position peaked at $8.39M in Q3 2013. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Zurich Cantonal Bank held 18,339 shares of Haemonetics worth $1.38M as of Q2 2026.
  • Zurich Cantonal Bank left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1349 holding.
  • Zurich Cantonal Bank first reported a position in Haemonetics in Q2 2013 and has held it in 48 quarters since.
  • Zurich Cantonal Bank's Haemonetics position peaked at $8.39M in Q3 2013.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.